Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marc Wilenzick"'
Publikováno v:
The BMJ
Objectives To develop and pilot a tool to measure and improve pharmaceutical companies’ clinical trial data sharing policies and practices. Design Cross sectional descriptive analysis. Setting Large pharmaceutical companies with novel drugs approve
Publikováno v:
BMJ Open
ObjectivesTo define a series of clinical trial transparency measures and apply them to large pharmaceutical and biotechnology companies and their 2014 FDA-approved drugs.DesignCross-sectional descriptive analysis of all clinical trials supporting 201
Autor:
Lynne Pauer, Kenneth A. Getz, Briggs W. Morrison, Marc Wilenzick, Diane Simmons, Zachary P. Hallinan, Zhanna Jumadilova, Marla J. Brickman
Publikováno v:
Expert Review of Clinical Pharmacology. 5:149-156
Although the overwhelming majority of study volunteers want to receive information on the results of their participation in clinical trials, research suggests that most study volunteers never do. CISCRP - an independent nonprofit organization - in co
Autor:
Mark Barnes, Marc Wilenzick, Barbara E. Bierer, Jeffrey K. Francer, Patricia Teden, Michelle M. Mello
Publikováno v:
The New England journal of medicine. 369(17)
The authors review the potential benefits and unintended consequences of the broad sharing of participant-level data from clinical trials. Several options for governance structures that could be implemented to provide expanded access to clinical tria